BioCentury
ARTICLE | Company News

Apogent Discoveries, Exact Sciences deal

December 16, 2002 8:00 AM UTC

EXAS received a license to Apogent’s Acrydite technology for use in manufacturing and using EXAS’s PreGen-Plus fecal DNA test for colorectal cancer. ...